Dental implants in individuals living with HIV-1: Results from a prospective study in patients undergoing highly active antiretroviral therapy.
HIV infections
dental implants
mucositis
peri-implantitis
Journal
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
ISSN: 1754-4505
Titre abrégé: Spec Care Dentist
Pays: United States
ID NLM: 8103755
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
29
07
2021
received:
20
05
2021
accepted:
21
08
2021
pubmed:
20
9
2021
medline:
16
3
2022
entrez:
19
9
2021
Statut:
ppublish
Résumé
To assess survival and success rates of dental implants and the occurrence of peri-implant diseases (mucositis/peri-implantitis) in HIV-1-infected individuals. In this prospective study, 13 HIV-1-infected individuals undergoing highly active antiretroviral therapy (with undetectable plasma HIV RNA levels, and CD4+ T cells > 350/mm All the implants healed uneventfully and reached 100% survival rates (after at least 18 months) in both groups. There were no significant differences between groups for peri-implant diseases (mucositis/peri-implantitis) and for all subject-level co-variables (p > .05). Only the variables dental implant prosthesis type (DIPT) (p = .021, d = .86) and follow up (p = .011, d = .77) showed statistically significant differences between groups. The findings suggest that well-controlled HIV-1-infected individuals are eligible to undergo implant therapy, achieving survival and success rates comparable to non-HIV-1-infected controls.
Substances chimiques
Dental Implants
0
Types de publication
Journal Article
Langues
eng
Pagination
112-119Informations de copyright
© 2021 Special Care Dentistry Association and Wiley Periodicals LLC.
Références
UNAIDS. Global HIV & AIDS statistics, 2018 fact sheet Available at: http://www.unaids.org/en/resources/fact-sheet Accessed January 4, 2019.
Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis. 2006;42:108-114.
Vidal F, Vidal R, Bochnia J, de Souza RC, Gonçalves LS. Dental implants and bone augmentation in HIV-infected patients under HAART: case report and review of the literature. Spec Care Dentist. 2017;37:150-155.
Hwang D, Wang HL. Medical contraindications to implant therapy: part II: relative fall. Implant Dent. 2007;16:13-23.
Bornstein MM, Cionca N, Mombelli A. Systemic conditions and treatments as risks for implant therapy. Int J Oral Maxilloafac Implants. 2009;24:12-27.
Romanos GE, Goldin E, Marotta L, Froum S, Tarnow DP. Immediate loading with fixed implant-supported restorations in an edentulous patient with an HIV infection: a case report. Implant Dent. 2014;23:8-12.
Gherlone EF, Capparé P, Tecco S, et al. A prospective longitudinal study on implant prosthetic rehabilitation in controlles HIV-positive patients with 1-year follow-up: the role of CD4+ level, smoking habits, and oral hygiene. Clin Implant Dent Relat Res. 2016;18:955-964.
Johnson MD, Decker CF. Osteonecrosis in HIV-infected persons: radiographic findings delay clinical diagnosis. AIDS Read. 2008;18:124-126. 132-3.
Oliveira MA, Gallottini M, Pallos D, Maluf PS, Jablonka F, Ortega KL. The success of endosseous implants in human immunodeficiency virus-positive patients receiving anti-retroviral therapy: a pilot study. J Am Dent Assoc. 2011;42:1010-1016.
Lemos CAA, Verri FR, Cruz RS, Santiago Júnior JF, Faverani LP, Pellizzer EP. Survival of dental implants placed in HIV-positive patients: a systematic review. Int J Oral Maxillofac Surg. 2018;47:1336-1342.
Ata-Ali J, Ata-Ali F, Di-Benedetto N, Bagán L, Bagán JV. Does HIV infection have an impact upon dental implant osseointegration? A systematic review. Med Oral Patol Oral Cir Buccal. 2015;20:e347-5.
Gay-Escoda C, Pérez-Álvarez D, Camps-Font O, Figueiredo R. Long-term outcomes of oral rehabilitation with dental implantes in HIV-positive patients: a retrospective case series. Med Oral Patol Oral Cir Bucal. 2016;21:e385-e391. http://doi.org/10.4317/medoral.21028
Sabbah A, Hicks J, MacNeill B, et al. A retrospective analysis of dental implant survival in HIV patients. J Clin Periodontol. 2019;46:363-372.
Chrcanovic BR, Albrektsson T, Wennerberg A. Reasons for failures of oral implants. J Oral Rehabil. 2014;41:443-476.
Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89(suppl. 1):S313-S318.
Dreyer H, Grischke J, Tiede C, et al. Epidemiology and risk factors of peri-implantitis: a systematic review. J Periodont Res. 2018;53:657-681.
Rajnay ZW, Hochstetter RL. Immediate placement of an endosseous root-form implant in an HIV-positive patient: report of a case. J Periodontol. 1998;69:1167-1171.
Buser D, Martin W, Belser C. Optimizing esthetics for implant restorations in the anterior maxilla: anatomic and surgical considerations. Int J Oral Maxillofac Implants. 2004;19(suppl):43-61.
Stevenson GC, Riano PC, Moretti AJ, Nichols CM, Engelmeier RL, Flaitz CM. Short-term success of osseointegrated dental implants in HIV-positive individuals: a prospective study. J Contemp Dent Pract. 2007;8:1-10.
Rania V, Pellegrino P, Donati G, Ghezzi M, Clementi E, Sparaco A. Long-term efficacy of dental implants in HIV-positive patients. Clin Infect Dis. 2015;61:1208.
Jarrin I, Pantazis N, Dalmau J, et al. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved? AIDS. 2015;29:2323-2333. http://doi.org/10.1097/qad.0000000000000805
Vissink A, Spijkervet FKL, Raghoebar GM. The medically compromised patient: are dental implants a feasible option? Oral Diseases. 2018;24:253-260.
Glick M, Abel SN, Muzyka BC, DeLorenzo M. Dental complications after treating patients with AIDS. J Am Dent Assoc. 1994;125:296-301.
Patton LL, McKaig R, Strauss R, Rogers D. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:299-304.
Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Factors influencing early dental implant failures. J Dent Res. 2016;95:995-1002.
May MC, Andrew PN, Daher S, Reebye UN. Prospective cohort study of dental implant success rate in patients with AIDS. Int J Implant Dent. 2016:2-20.
Renvert S, Quirynen M. Risk indicators for peri-implantitis. A narrative review. Clin Oral Implants Res. 2015;26(Suppl.11):15-44.
Katafuchi M, Weinstein B, Leroux B, Chen Y, Daubert DM. Restoration contour is a risk indicator for peri-implantitis: a cross-sectional radiographic analysis. J Clin Periodontol. 2018;45:225-232.
Lee CT, Huang YW, Zhu L, Weltman R. Prevalences of peri-implantitis and peri-implant mucositis: systematic review and meta-analysis. J Dent. 2017;62:1-12.
Zandim-Barcelos D, Carvalho G, Sapata V, Villar C, Hammerle C, Romito G. Implant-based factor as possible risk for peri-implantitis. Braz Oral Res. 2019;33(Suppl. 1):e067.
Rubinstein NC, Jacobson Z, McCausland GL, Dibart S. Retrospective study of the success of dental implants placed in HIV-positive patients. Int J Implant Dent. 2019;5:30.